Treace Medical Concepts Statistics
Total Valuation
TMCI has a market cap or net worth of $182.29 million. The enterprise value is $190.37 million.
Important Dates
The last earnings date was Friday, May 8, 2026, before market open.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TMCI has 64.87 million shares outstanding. The number of shares has increased by 2.28% in one year.
| Current Share Class | 64.87M |
| Shares Outstanding | 64.87M |
| Shares Change (YoY) | +2.28% |
| Shares Change (QoQ) | +1.15% |
| Owned by Insiders (%) | 25.55% |
| Owned by Institutions (%) | 44.03% |
| Float | 48.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.82 |
| Forward PS | 0.81 |
| PB Ratio | 2.12 |
| P/TBV Ratio | 2.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.58, with a Debt / Equity ratio of 0.93.
| Current Ratio | 3.58 |
| Quick Ratio | 2.40 |
| Debt / Equity | 0.93 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.99 |
Financial Efficiency
Return on equity (ROE) is -66.88% and return on invested capital (ROIC) is -21.54%.
| Return on Equity (ROE) | -66.88% |
| Return on Assets (ROA) | -17.87% |
| Return on Invested Capital (ROIC) | -21.54% |
| Return on Capital Employed (ROCE) | -37.26% |
| Weighted Average Cost of Capital (WACC) | 9.11% |
| Revenue Per Employee | $460,707 |
| Profits Per Employee | -$135,647 |
| Employee Count | 450 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 1.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.32% in the last 52 weeks. The beta is 1.11, so TMCI's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -63.32% |
| 50-Day Moving Average | 1.68 |
| 200-Day Moving Average | 3.79 |
| Relative Strength Index (RSI) | 73.29 |
| Average Volume (20 Days) | 407,253 |
Short Selling Information
The latest short interest is 3.96 million, so 6.11% of the outstanding shares have been sold short.
| Short Interest | 3.96M |
| Short Previous Month | 4.83M |
| Short % of Shares Out | 6.11% |
| Short % of Float | 8.20% |
| Short Ratio (days to cover) | 4.26 |
Income Statement
In the last 12 months, TMCI had revenue of $207.32 million and -$61.04 million in losses. Loss per share was -$0.96.
| Revenue | 207.32M |
| Gross Profit | 165.27M |
| Operating Income | -55.74M |
| Pretax Income | -61.04M |
| Net Income | -61.04M |
| EBITDA | -47.68M |
| EBIT | -55.74M |
| Loss Per Share | -$0.96 |
Full Income StatementBalance Sheet
The company has $51.85 million in cash and $71.60 million in debt, with a net cash position of -$19.75 million or -$0.30 per share.
| Cash & Cash Equivalents | 51.85M |
| Total Debt | 71.60M |
| Net Cash | -19.75M |
| Net Cash Per Share | -$0.30 |
| Equity (Book Value) | 77.19M |
| Book Value Per Share | 1.19 |
| Working Capital | 88.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.93 million and capital expenditures -$13.04 million, giving a free cash flow of -$25.96 million.
| Operating Cash Flow | -12.93M |
| Capital Expenditures | -13.04M |
| Depreciation & Amortization | 8.06M |
| Net Borrowing | 3.17M |
| Free Cash Flow | -25.96M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
Gross margin is 79.72%, with operating and profit margins of -26.89% and -29.44%.
| Gross Margin | 79.72% |
| Operating Margin | -26.89% |
| Pretax Margin | -29.44% |
| Profit Margin | -29.44% |
| EBITDA Margin | -23.00% |
| EBIT Margin | -26.89% |
| FCF Margin | n/a |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.28% |
| Shareholder Yield | -2.28% |
| Earnings Yield | -35.78% |
| FCF Yield | -15.22% |
Analyst Forecast
The average price target for TMCI is $4.77, which is 69.75% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.77 |
| Price Target Difference | 69.75% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMCI has an Altman Z-Score of 0.4 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.4 |
| Piotroski F-Score | 2 |
